Polyclonal rabbit anti-human CCDC88B antiserum was prepared as we have previously described5 (link),34 (link). A recombinant protein consisting of glutathione-S-transferase (GST) fused in-frame to a CCDC88B segment corresponding to human amino acid positions 650 to 769, was expressed in E. coli BL21, followed by affinity purification with glutathione-agarose beads (GE Healthcare). Antisera were raised in New Zealand white rabbits using purified protein (0.5 mg per rabbit per injection) emulsified in Freund’s incomplete adjuvant. Affinity purification of the anti-CCDC88B antibody35 (link) was using a recombinant CCDC88B protein (positions 650 to 769) comprising a poly-histidine tail (His)6 fused in-frame at its N terminus, and purified by chromatography onto Ni-NTA agarose (Qiagen). The immobilized protein was used to capture the anti-CCDC88B fraction of the hyperimmune serum, which was then released by washing with imidazole-containing buffer34 (link). The specificity of the anti-CCDC88B antibody was tested by western blotting total cell extracts from HEK293T control cells and HEK293T cells (ATCC, CRL-11268) stably expressing a full-length human CCDC88B.
Free full text: Click here